<DOC>
	<DOCNO>NCT00514098</DOCNO>
	<brief_summary>A new approach HIV prevention currently study include use topical microbicides orally administer anti-HIV drug . The purpose study well understand impact microbicides woman diagnose HIV-1 participation previous microbicide trial .</brief_summary>
	<brief_title>Observational Study HIV Infected Women Previously Enrolled Other Microbicide Trials</brief_title>
	<detailed_description>It necessary monitor HIV long period time order well understand impact microbicides anti-HIV drug progression HIV infection become infected unknowingly already infect receive drug . The purpose study determine effect microbicides oral anti-HIV drug time HIV infect woman previously enrol microbicide trial . The study remain open accrual duration MTN funding , use two follow-up visit schedule , one base date diagnosis parent study , one base initiation antiretroviral treatment ( ART ) . Participants initiated ART time enrollment study follow schedule base date diagnosis . Participants already begin ART time enrollment follow schedule base date ART initiation . Individuals enrol start date base date ART initiation first follow-up visit Week 2 resume rest schedule . On schedule , follow-up visit occur Months 1 , 3 , 6 every 6 month thereafter . Interim visit may perform time follow-up , participant ask attend final study visit prior termination study . Participants may enroll time HIV diagnosis leave study time . A physical exam ; medical medication history assessment ; blood urine collection ; pelvic , cervicovaginal lavage , vaginal swab sample occur visit . A behavioral assessment occur select visit , adherence social harm assessment occur visit . Sexually transmitted infection risk reduction/contraception HIV-1 secondary counseling occur visit . In addition , condom provide visit reduce HIV transmission . ART provide study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Diagnosis HIV1 infection participation Microbicide Trials Network ( MTN ) clinical trial ( include HPTN 035 HPTN 059 ) , accord HIV test algorithm parent MTN trial Parent guardian willing provide inform consent , applicable Any condition , opinion investigator , make participation study unsafe interferes study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Microbicide</keyword>
	<keyword>Seroconversion</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>